Granules India Limited
American Funds (Capital Group) increased its stake in Granules India Limited from 1.39% to 1.59%, buying an additional 511,120 shares. The value of the additional shares is ₹42.59 Cr, based on the last closing price of ₹833.80.
A pharmaceutical manufacturer engaged in producing Active Pharma Ingredients, Pharmaceutical Formulation Intermediates, and finished dosages for global markets. Granules India operates integrated manufacturing facilities across multiple locations in India, serving domestic and international customers in the pharmaceutical sector. The company specializes in complex chemical synthesis and formulation development for various therapeutic categories, including antibiotics, cardiovascular, and gastroenterology segments.
India equity holdings of American Funds, the mutual fund family of Capital Group. Long-only, fundamentally driven strategy.